You just read:

Taiho Oncology, Inc. Announces Results from TAS-102 Global Phase III RECOURSE Trial in Refractory Metastatic Colorectal Cancer

News provided by

Taiho Oncology, Inc.

28 Jun, 2014, 11:30 BST